HURA TuHURA Biosciences, Inc.
$2.11▲ +3.43%
Healthcare
Other
After hours
$2.12▲ +0.47%
Oct 27, 5:19 PM ET
Volume 398.1K
Avg Volume (10D) 421.9K
Key Metrics & Fundamentals
Market Cap
$134.46M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.41 - 3.43
% vs 50 MA
3.79%
% vs 200 MA
8.08%
RSI-14
55.9
MACD Histogram
+0.0400
Beta (1Y vs SPY)
3.14
Free Cash Flow
-$8.77M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$8.73M
COGS
–
Operating Exp
$8.76M
Operating Income
-$8.76M
EBIT
-$8.76M
Pretax Income
-$9.22M
Net Income
-$9.22M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
TuHURA Reports Early Responses in Deep-Seated Merkel Cell Cancer Study
MarketBeat · Oct 26, 2026 4:02 PM ET
TuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line Treatment of Patients with Deep Seated Metastatic Merkel Cell Carcinoma
PR Newswire · Oct 26, 2026 7:30 AM ET
TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025
PR Newswire · Oct 13, 2026 7:45 AM ET
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology
PR Newswire · Oct 5, 2026 7:45 AM ET
TuHURA Biosciences Says FDA Clears Phase 1b Trial of TBS-2025 in Acute Myeloid Leukemia
MT Newswires · Sep 14, 2026 9:17 AM ET
TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood-Related Cancers
PR Newswire · Sep 14, 2026 7:45 AM ET
TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 8, 2026 7:45 AM ET
HURA: Milestone Progression Over Next 12 Months
Zacks Small Cap Research · Aug 26, 2026 5:12 AM ET
TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord
MarketBeat · Aug 14, 2026 11:05 AM ET
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
PR Newswire · Aug 14, 2026 7:45 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See HURA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.